Background
==========

Imatinib (IM) inhibits the TK protein from chromosome Philadelphia (Ph). However, less than 10% of IM-treated patients become resistant. Second generation TK inhibitors are on active clinical research aimed to overcome most, but not all, important mutations.

Case report
===========

A 61 year-old male was diagnosed on Sep/98 with CML chronic phase, he was treated with hydroxiurea, interferon and Ara-C. On July/01 the patient was on complete hematological response (CHR), but Ph positive in karyotyping (Ky) and fluorescence *in-situ*hybridization (FISH), there were not additional abnormalities. Patient began IM treatment, 400 mg/day. After 4 months of treatment, +der(22) was detected, but the patient was still on CHR. On subsequent visits, the patient had an increased frequency of chromosomal abnormalities, and after 2 years he lost CHR, regardless of the increase IM dose and the concomitant use of Ara-C. The patient was included on a dasatinib phase II protocol. 2 weeks after he had a profound cytopenia and 2 months after had CHR. Table [1](#T1){ref-type="table"} shows clinical and hematological and Ky and FISH follow-up.

Conclusion
==========

Additional abnormalities found on Ky and FISH could preceed treatment failure. Molecular monitoring is required to guide treatment decisions. The role of second generation TK inhibitors needs to be defined.

Figures and Tables
==================

###### 

Clinical and hematological and Ky and FISH follow-up

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Sample   Date      Ky                                                                                FISH                                                   Treatment & clinical condition
  -------- --------- --------------------------------------------------------------------------------- ------------------------------------------------------ --------------------------------
  1        Jul/01    Only Ph                                                                           Only Ph 35%                                            Began IM 400 mg/d CHR

  2        Nov/01    Ph plus double Ph                                                                 Not enough material                                    IM 400 mg/d CHR

  3        Jan/02    No growth                                                                         Only Ph 26%                                            IM 400 mg/d CHR

  4        Sep/02    Hipodiploid plus Ph                                                               Only Ph 22%\                                           IM 400 mg/d Leucocytosis
                                                                                                       Clone BCR amplified without Ph 3%\                     
                                                                                                       Clone ABL amplified and Ph 5%                          

  5        Jun/03    Only Ph                                                                           Only Ph = 28%\                                         IM 600 mg/d
                                                                                                       Clone BCR amplified without Ph = 1%\                   
                                                                                                       Clone ABL and/or BCR amplified with Ph = 28%\          
                                                                                                       Clone ABL and/or BCR amplified and double Ph = 51%\    
                                                                                                       Clone ABL and BCR amplified with triple Ph = 11%\      
                                                                                                       Clone ABL lost with Ph = 5%                            

  6        Nov/03    Ph plus lost Y, marker chromosome, trisomy chr 19, double Ph and trisomy chr 8.   Only Ph = 4%\                                          IM 600 mg + Ara-C
                                                                                                       Clone ABL amplified without Ph = 1%\                   
                                                                                                       Clone ABL and/or BCR amplified with Ph = 18%\          
                                                                                                       Clone ABL and/or BCR amplified with double Ph = 74%\   
                                                                                                       Clone ABL and BCR amplified with triple PH = 1%\       
                                                                                                       Trisomy chr 8 = 72%                                    

  7        Jul/04    No growth                                                                         Only Ph = 44%\                                         IM 800 mg/d
                                                                                                       Clone ABL amplified with Ph = 6%\                      
                                                                                                       Clone ABL and/or BCR amplified with double Ph = 17%    

  sample   Jan/ 05                                                                                                                                            Began with dasatinib

  8        Dec/05    No growth                                                                         Only Ph = 18%                                          Dasatinib
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
